Monosialotetrahexosylganglioside Sodium

单唾液酸四己糖神经节苷脂钠

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameMonosialotetrahexosylganglioside Sodium
Drug Alias NameMonosialotetrahexosylgangliosideLiposomal monosialotetrahexosylgangliosideLiposomal GM1Sodium MonosialotettrahexosylgangliosideMonosialoganglioside +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNervous system modulators
TargetsUpdating
Therapy Area/IndicationsIschemic StrokeCraniocerebral TraumaPeripheral Nervous System Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesInnoMedica Schweiz AG
China Registration ClassN/A

Develop Information

Active CompaniesInnoMedica Schweiz AGQilu Pharmaceutical Co Ltd
Inactive CompaniesSun Yat-Sen University
Active IndicationsIschemic StrokeCraniocerebral TraumaPeripheral Nervous System Diseases +[5] 
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A